$1.14
2.16% today
Nasdaq, Apr 04, 09:14 pm CET
ISIN
US4495851085
Symbol
IGMS
Sector
Industry

IGM Biosciences Inc Target price 2025 - Analyst rating & recommendation

IGM Biosciences Inc Classifications & Recommendation:

Hold
88%
Sell
13%

IGM Biosciences Inc Price Target

Target Price $2.18
Price $1.16
Potential
Number of Estimates 7
7 Analysts have issued a price target IGM Biosciences Inc 2026 . The average IGM Biosciences Inc target price is $2.18. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 0 Analysts recommend IGM Biosciences Inc to buy, 7 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the IGM Biosciences Inc stock has an average upside potential 2026 of . Most analysts recommend the IGM Biosciences Inc stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 2.68 5.43
25.82% 102.52%
EBITDA Margin -6,907.09% -810.85%
42.35% 88.26%
Net Margin -7,211.42% -1,055.05%
45.33% 85.37%

8 Analysts have issued a sales forecast IGM Biosciences Inc 2025 . The average IGM Biosciences Inc sales estimate is

$5.4m
Unlock
. This is
102.52% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$24.0m 796.27%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.7m 25.82%
2025
$5.4m 102.52%
Unlock
2026
$9.1m 68.35%
Unlock
2027
$15.8m 73.23%
Unlock
2028
$28.1m 77.36%
Unlock

2 Analysts have issued an IGM Biosciences Inc EBITDA forecast 2025. The average IGM Biosciences Inc EBITDA estimate is

$-44.0m
Unlock
. This is
76.22% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-36.6m 80.22%
Unlock
, the lowest is
$-51.4m 72.22%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-185m 27.46%
2025
$-44.0m 76.23%
Unlock
2026
$-35.0m 20.55%
Unlock
2027
$-33.3m 4.87%
Unlock

EBITDA Margin

2024 -6,907.09% 42.35%
2025
-810.85% 88.26%
Unlock
2026
-382.69% 52.80%
Unlock
2027
-210.16% 45.08%
Unlock

5 IGM Biosciences Inc Analysts have issued a net profit forecast 2025. The average IGM Biosciences Inc net profit estimate is

$-57.3m
Unlock
. This is
70.46% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-5.4m 97.23%
Unlock
, the lowest is
$-120m 37.85%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-193m 31.21%
2025
$-57.3m 70.37%
Unlock
2026
$-9.2m 84.02%
Unlock
2027
$-890k 90.27%
Unlock
2028
$8.7m 1,071.91%
Unlock

Net Margin

2024 -7,211.42% 45.33%
2025
-1,055.05% 85.37%
Unlock
2026
-100.10% 90.51%
Unlock
2027
-5.65% 94.36%
Unlock
2028
30.81% 645.31%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -3.24 -0.96
31.21% 70.37%
P/E negative
EV/Sales negative

5 Analysts have issued a IGM Biosciences Inc forecast for earnings per share. The average IGM Biosciences Inc EPS is

$-0.96
Unlock
. This is
70.46% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.09 97.23%
Unlock
, the lowest is
$-2.02 37.85%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.24 31.21%
2025
$-0.96 70.37%
Unlock
2026
$-0.15 84.38%
Unlock
2027
$-0.02 86.67%
Unlock
2028
$0.15 850.00%
Unlock

P/E ratio

Current -0.36 82.00%
2025
-1.21 236.11%
Unlock
2026
-7.57 525.62%
Unlock
2027
-77.33 921.53%
Unlock
2028
8.00 110.35%
Unlock

Based on analysts' sales estimates for 2025, the IGM Biosciences Inc stock is valued at an EV/Sales of

-12.79
Unlock
and an P/S ratio of
12.78
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -25.90 120.47%
2025
-12.79 50.62%
Unlock
2026
-7.60 40.60%
Unlock
2027
-4.39 42.27%
Unlock
2028
-2.47 43.62%
Unlock

P/S ratio

Current 25.87 90.29%
2025
12.78 50.62%
Unlock
2026
7.59 40.60%
Unlock
2027
4.38 42.27%
Unlock
2028
2.47 43.62%
Unlock

Current IGM Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
Locked
Locked Jan 13 2025
BMO Capital
Locked
Locked
Locked Jan 10 2025
RBC Capital
Locked
Locked
Locked Jan 10 2025
Jefferies
Locked
Locked
Locked Jan 10 2025
Stifel
Locked
Locked
Locked Jan 10 2025
Truist Securities
Locked
Locked
Locked Jan 10 2025
BMO Capital
Locked
Locked
Locked Dec 06 2024
Analyst Rating Date
Locked
JP Morgan:
Locked
Locked
Jan 13 2025
Locked
BMO Capital:
Locked
Locked
Jan 10 2025
Locked
RBC Capital:
Locked
Locked
Jan 10 2025
Locked
Jefferies:
Locked
Locked
Jan 10 2025
Locked
Stifel:
Locked
Locked
Jan 10 2025
Locked
Truist Securities:
Locked
Locked
Jan 10 2025
Locked
BMO Capital:
Locked
Locked
Dec 06 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today